Drugs / SZ003 CAR-NK
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05845502 | Jul 2021 → Sep 2024 | hepatocellular carcinoma | Shantou University Medical College | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SZ003 CAR-NK | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05845502 ↗ |
| Modality | Cell therapy | “Biological: SZ003 CAR-NK” NCT05845502 ↗ |
| Route | Other | “The infusion is given every 2 weeks.” NCT05845502 ↗ |